Joseph Frattaroli - Net Worth and Insider Trading
Joseph Frattaroli Net Worth
The estimated net worth of Joseph Frattaroli is at least $23,163 dollars as of 2024-11-13. Joseph Frattaroli is the CFO of Inhibikase Therapeutics Inc and owns about 8,015 shares of Inhibikase Therapeutics Inc (IKT) stock worth over $23,163. Details can be seen in Joseph Frattaroli's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Frattaroli has not made any transactions after 2022-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph Frattaroli
Joseph Frattaroli Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Frattaroli owns 1 companies in total, including Inhibikase Therapeutics Inc (IKT) .
Click here to see the complete history of Joseph Frattaroli’s form 4 insider trades.
Insider Ownership Summary of Joseph Frattaroli
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IKT | Inhibikase Therapeutics Inc | 2022-05-19 | Cheif Financial Officer |
Joseph Frattaroli Latest Holdings Summary
Joseph Frattaroli currently owns a total of 1 stock. Joseph Frattaroli owns 8,015 shares of Inhibikase Therapeutics Inc (IKT) as of May 19, 2022, with a value of $23,163.
Latest Holdings of Joseph Frattaroli
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics Inc | 2022-05-19 | 8,015 | 2.89 | 23,163 |
Holding Weightings of Joseph Frattaroli
Joseph Frattaroli Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph Frattaroli has made a total of 1 transactions in Inhibikase Therapeutics Inc (IKT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Inhibikase Therapeutics Inc is the acquisition of 658 shares on May 19, 2022, which cost Joseph Frattaroli around $2,527.
Insider Trading History of Joseph Frattaroli
- 1
Joseph Frattaroli Trading Performance
GuruFocus tracks the stock performance after each of Joseph Frattaroli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Frattaroli is 19.83%. GuruFocus also compares Joseph Frattaroli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Frattaroli within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph Frattaroli's insider trading performs compared to the benchmark.
Performance of Joseph Frattaroli
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 38.1 | | | | | |
| Relative Return to S&P 500(%) | 43.89 | | | | | |
Joseph Frattaroli Ownership Network
Ownership Network List of Joseph Frattaroli
Ownership Network Relation of Joseph Frattaroli
Joseph Frattaroli Owned Company Details
What does Inhibikase Therapeutics Inc do?
Who are the key executives at Inhibikase Therapeutics Inc?
Joseph Frattaroli is the Cheif Financial Officer of Inhibikase Therapeutics Inc. Other key executives at Inhibikase Therapeutics Inc include director & 10 percent owner & President and CEO Milton H. Werner , and 10 percent owner Daniel Kalman .
Inhibikase Therapeutics Inc (IKT) Insider Trades Summary
Over the past 18 months, Joseph Frattaroli made no insider transaction in Inhibikase Therapeutics Inc (IKT). Other recent insider transactions involving Inhibikase Therapeutics Inc (IKT) include a net purchase of 1,460,000 shares made by , a net purchase of 365,000 shares made by Amit Munshi , and a net purchase of 145,000 shares made by Arvind Kush .
In summary, during the past 3 months, insiders sold 0 shares of Inhibikase Therapeutics Inc (IKT) in total and bought 1,970,000 shares, with a net purchase of 1,970,000 shares. During the past 18 months, 0 shares of Inhibikase Therapeutics Inc (IKT) were sold and 1,970,000 shares were bought by its insiders, resulting in a net purchase of 1,970,000 shares.
Inhibikase Therapeutics Inc (IKT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibikase Therapeutics Inc Insider Transactions
Joseph Frattaroli Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Frattaroli. Currently GuruFocus does not have mailing address information for Joseph Frattaroli.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
